|
ZBTB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62558855265615E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.05910893575401E-12 |
| Normal-vs-Stage2 |
7.637500E-04 |
| Normal-vs-Stage3 |
1.90358839802229E-12 |
| Normal-vs-Stage4 |
1.0325074129014E-14 |
| Stage1-vs-Stage2 |
6.256000E-02 |
| Stage1-vs-Stage3 |
2.220200E-03 |
| Stage1-vs-Stage4 |
1.09780000001614E-06 |
| Stage2-vs-Stage3 |
1.201600E-03 |
| Stage2-vs-Stage4 |
2.21679999999891E-05 |
| Stage3-vs-Stage4 |
5.772400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.8337999441751E-11 |
| Normal-vs-AfricanAmerican |
1.14350000002261E-06 |
| Normal-vs-Asian |
2.60289999554075E-08 |
| Caucasian-vs-AfricanAmerican |
5.755200E-01 |
| Caucasian-vs-Asian |
3.173600E-01 |
| AfricanAmerican-vs-Asian |
2.933800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.37000002850851E-09 |
| Normal-vs-Female |
1.34599997814178E-10 |
| Male-vs-Female |
4.263400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.35689961675712E-10 |
| Normal-vs-Age(41-60Yrs) |
6.88338275267597E-15 |
| Normal-vs-Age(61-80Yrs) |
6.65760002682703E-10 |
| Normal-vs-Age(81-100Yrs) |
2.956300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.075360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.261600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.940400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.484200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.196400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.456800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.51520000002403E-06 |
| Classical-VS-Follicular |
2.34419999999291E-05 |
| Classical-VS-Other |
7.518400E-01 |
| Classical-VS-Normal |
1.06309960834494E-10 |
| Tall-VS-Follicular |
2.42199593714076E-11 |
| Tall-VS-Other |
1.799430E-01 |
| Tall-VS-Normal |
3.10862446895044E-15 |
| Follicular-VS-Other |
2.693600E-01 |
| Follicular-VS-Normal |
1.395860E-03 |
| Other-VS-Normal |
1.062110E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.03819977456976E-10 |
| Normal-vs-N1 |
1.71773706370004E-12 |
| N0-vs-N1 |
2.42049999998883E-06 |
|
|
